Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
OWA Status Updating trust level from 1 to 0 Gäst
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Gäst
User created User created Gäst
OWA Status Updating trust level from 1 to 0 Gäst
Profile edited Profile edited Gäst
OWA Status slovenia@progress.im manually updating trust level from 1 to 5 Gäst
Newsletter subscribed Newsletter subscribed - PROGRESS IN MIND SLOVENIJA E-NOVICE Gäst
User created User created Gäst
OWA Status Updating trust level from 1 to 2 Gäst
User created User created Gäst
User created User created Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
User created User created Gäst
OWA Status Updating trust level from 1 to 2 Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
User created User created Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter clicked Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados Convite Lundbeck Webinar Internacional Gäst
Newsletter clicked Clicked https://brazil.progress.im/en/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados Convite Lundbeck Webinar Internacional Gäst
Newsletter opened Opened Convite Lundbeck Webinar Internacional Gäst
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
OWA Status Updating trust level from 1 to 0 Gäst
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Gäst
User created User created Gäst
OWA Status Updating trust level from 1 to 0 Gäst
Profile edited Profile edited Gäst
OWA Status slovenia@progress.im manually updating trust level from 1 to 5 Gäst
Newsletter subscribed Newsletter subscribed - PROGRESS IN MIND SLOVENIJA E-NOVICE Gäst
User created User created Gäst
OWA Status Updating trust level from 1 to 2 Gäst
User created User created Gäst
User created User created Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
User created User created Gäst
OWA Status Updating trust level from 1 to 2 Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
User created User created Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter clicked Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados Convite Lundbeck Webinar Internacional Gäst
Newsletter clicked Clicked https://brazil.progress.im/en/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados Convite Lundbeck Webinar Internacional Gäst
Newsletter opened Opened Convite Lundbeck Webinar Internacional Gäst